Data Bridge Market Research analyses a growth rate in the glycopeptide antibiotics market in the forecast period 2023-2030. The expected CAGR of glycopeptide antibiotics market is tend to be around 10% in the mentioned forecast period. The market was valued at USD 3.07 billion in 2022, and it would grow up to USD 6.6 billion by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Growing incidence of cancer and other infectious diseases are anticipated to increase the growth during the forecast period. The common glycopeptides that are currently used in clinical practice to treat enterococcal infections are teicoplanin and vancomycin. The growth of glycopeptide antibiotics market is increased by the growing cases of numerous infectious diseases and emerging launches in research and development activities that are conducted by many pharmaceuticals’ companies.

View Report: https://www.databridgemarketresearch.com/reports/global-glycopeptid...

Opportunities

Increasing Demand of Retail Pharmacies
The increase in the number of narcotic drugs which is delivered through retail pharmacies and the rise in the number of retail pharmacies in developing and developed countries create opportunities for the market growth. Additionally, patients choose retail pharmacies for purchasing drugs, as these are easily available.

Higher Efficiency of Novel Drugs
The efficiency of several existing products is anticipated to result into increasing revenues due to doctor recommendations. For instance, BLEOMYCIN for injection USP is the mixture of cytotoxic glycopeptide antibiotics which is isolated from Streptomyces verticillus and is widely used for the treatment of testicular carcinoma, squamous cell carcinoma, and various types of lymphomas.

Glycopeptide Antibiotics Market Scope

The glycopeptide antibiotics market is segmented on the basis of drugs, indication, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Drugs

Vancomycin
Dalbavancin
Oritavancin
Others
Indication

Skin and Structure Infection
Meningitis
Clostridioides Difficile Infection
Enterocolitis
Others
Route of Administration

Oral
Parenteral
Others
End-Users

Hospitals
Specialty Clinics
Homecare
Others
Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others

Key players operating in the glycopeptide antibiotics market include:

ANI Pharmaceuticals, Inc. (U.S.)
Fresenius SE & Co. KGaA (Germany)
Pfizer Inc (U.S.)
Mylan N.V. (U.S.)
Novartis AG (U.S.),
Hikma Pharmaceuticals plc (U.K.)
Aurobindo Pharma (India)
Abbvie, Inc (U.S.)
Melinta Therapeutics, Inc (U.S.)
Cumberland Pharmaceuticals Inc (U.S.)
Theravance Biopharma (U.S.)
Janssen Global Services, LLC (U.S.)
Bristol-Myers Squibb Company (U.S.)
GSK plc. (U.K.)
Bayer AG (U.S.)

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:-

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475

Email:- [email protected]